GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Aim Pharm Inc (SZSE:002826) » Definitions » E10

Tibet Aim Pharm (SZSE:002826) E10 : ¥0.30 (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Tibet Aim Pharm E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Tibet Aim Pharm's adjusted earnings per share data for the fiscal year that ended in Dec. 2022 was ¥0.230. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.30 for the trailing ten years ended in Dec. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-09-21), Tibet Aim Pharm's current stock price is ¥ 7.66. Tibet Aim Pharm's E10 for the fiscal year that ended in Dec. 2022 was ¥0.30. Tibet Aim Pharm's Shiller PE Ratio of today is 25.53.

During the past 10 years, the highest Shiller PE Ratio of Tibet Aim Pharm was 39.57. The lowest was 25.10. And the median was 36.93.


Tibet Aim Pharm E10 Historical Data

The historical data trend for Tibet Aim Pharm's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Aim Pharm E10 Chart

Tibet Aim Pharm Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.30

Tibet Aim Pharm Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Tibet Aim Pharm's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Tibet Aim Pharm's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tibet Aim Pharm's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tibet Aim Pharm's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Tibet Aim Pharm's Shiller PE Ratio falls into.



Tibet Aim Pharm E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Tibet Aim Pharm's adjusted earnings per share data for the fiscal year that ended in Dec. 2022 was:

Adj_EPS=Earnings per Share (Diluted) /CPI of Dec. 2022 (Change)*Current CPI (Dec. 2022)
=0.23/115.1156*115.1156
=0.230

Current CPI (Dec. 2022) = 115.1156.

Tibet Aim Pharm Annual Data

per_share_eps CPI Adj_EPS
201312 0.394 97.624 0.465
201412 0.240 99.000 0.279
201512 0.370 100.600 0.423
201612 0.380 102.600 0.426
201712 0.320 104.500 0.353
201812 0.130 106.500 0.141
201912 0.200 111.200 0.207
202012 0.220 111.500 0.227
202112 0.220 113.108 0.224
202212 0.230 115.116 0.230

Add all the adjusted EPS together and divide 10 will get our e10.


Tibet Aim Pharm  (SZSE:002826) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Tibet Aim Pharm's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=7.66/0.3
=25.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 10 years, the highest Shiller P/E Ratio of Tibet Aim Pharm was 39.57. The lowest was 25.10. And the median was 36.93.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Tibet Aim Pharm E10 Related Terms

Thank you for viewing the detailed overview of Tibet Aim Pharm's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Tibet Aim Pharm Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Linqionggang Road, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000
Tibet Aim Pharm Inc is the pharmaceutical company based in China. It is mainly engaged in the research and development, production and sales of chemical drugs and proprietary Chinese medicines for common chronic disease such as diabetes and cardiovascular disease as well as medicines for gynecology and obstetrics. The company's products offering includes miglitol tablets, gualoupi injection, nalmefene hydrochloride injection, carbetocin injection; hongjin xiaojie tablets and aceclofenac enteric-coated tablets. The company also expanded its products in the treatment of antibiotic, antiallergic and digestive system.
Executives
Peng Hui Director
Pang Guo Qiang Directors, executives
Li Qian Jin Securities Affairs Representative
Liu Hang Supervisors

Tibet Aim Pharm Headlines

No Headlines